3,5-dihydroxyphenylglycine has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Cheng, HP; Guo, C; Sun, Q; Tang, TS; Wang, JQ; Wang, QC; Wang, X; Wang, Y | 1 |
| Bernardi, G; Calabresi, P; Centonze, D; Pisani, A | 1 |
2 other study(ies) available for 3,5-dihydroxyphenylglycine and Huntington Disease
| Article | Year |
|---|---|
Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.
Topics: Animals; Bradykinin; Calcium; Calcium Channels; Calcium Signaling; DNA Damage; DNA, Mitochondrial; Embryo, Mammalian; Female; Fibroblasts; Genome, Mitochondrial; Glycine; Humans; Huntington Disease; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Transgenic; Mitochondria; Neostriatum; Neurons; Resorcinols; Superoxides | 2013 |
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease.
Topics: Animals; Brain Ischemia; Calcium Channels; Cell Communication; Cells, Cultured; Cerebral Cortex; Cholinergic Fibers; Corpus Striatum; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glycine; Huntington Disease; Interneurons; Male; Membrane Potentials; Protein Kinase C; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Resorcinols | 1999 |